Atara Biotherapeutics Exercises Exclusive License to T-Cell Technology From Memorial Sloan Kettering Cancer Center Jun 15, 2015 6:30am EDT
Atara Biotherapeutics, Inc. to Present at Upcoming Investor Conferences in June 2015 May 27, 2015 6:30am EDT
Update: Atara Biotherapeutics' Collaborating Investigators to Present Data at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting May 20, 2015 6:30am EDT
Atara Biotherapeutics' Collaborating Investigators to Present Data at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting May 14, 2015 6:30am EDT
Atara Biotherapeutics, Inc. to Present at the UBS Global Healthcare Conference May 12, 2015 6:30am EDT
EBV-CTL Clinical Trial Data Presented by Atara Biotherapeutics' Collaborating Investigators at a Plenary Session at the American Association for Cancer Research Annual Meeting 2015 Apr 20, 2015 6:30am EDT
Atara Biotherapeutics' Collaborating Investigators' Abstract on T-Cell Therapy for EBV Lymphoma to be Presented at a Clinical Trials Plenary Session at the American Association for Cancer Research Annual Meeting 2015 is Now Available Apr 19, 2015 8:30am EDT
Atara Biotherapeutics, Inc. to Present at the 2015 Jefferies Immuno-Oncology Summit Apr 13, 2015 6:30am EDT
